THNR
Amplify Weight Loss Drug & Treatment ETF
1W: -4.4%
1M: -9.0%
3M: -7.5%
YTD: -3.4%
1Y: -0.2%
$24.56
-0.13 (-0.54%)
Weekly Expected Move ±2.8%
$23
$24
$25
$25
$26
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Key Statistics
AUM$5M
Holdings21
Top 10 Wt59.8%
Volume2,074
Avg Volume1,818
Beta0.40
Portfolio Fundamentals
P/E20.4
P/B5.0
Div Yield2.01%
ROE25.9%
% Profitable55%
Inception2024-05-21
Sector Allocation
Healthcare
96.1%
Financial Services
3.0%
Other
0.9%
Top 10 Holdings
| # | Name | Ticker | Weight % | Market Value | Shares |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 10.07% | $582,011 | 503 |
| 2 | Novo Nordisk A/S | NVO | 8.42% | $486,575 | 12,835 |
| 3 | CSPC Pharmaceutical Group Ltd | 1093.HK | 5.82% | $336,233 | 262,000 |
| 4 | Amgen Inc | AMGN | 5.75% | $332,150 | 788 |
| 5 | Pfizer Inc | PFE | 5.38% | $310,754 | 10,896 |
| 6 | Innovent Biologics Inc | 1801.HK | 5.30% | $306,143 | 24,500 |
| 7 | AstraZeneca PLC | AZN | 5.27% | $304,855 | 1,888 |
| 8 | Regeneron Pharmaceuticals Inc | REGN | 4.64% | $268,428 | 354 |
| 9 | AbbVie Inc | ABBV | 4.56% | $263,421 | 1,007 |
| 10 | Roche Holding AG | ROP.SW | 4.56% | $263,409 | 630 |